Biography & Research:
Professor Beka Solomon earned her PhD in 1976 from the Weizmann Institute of Science, Rehovoth, Israel. She joined Tel Aviv University in 1979 following post-doctoral studies and training periods at Harvard Medical School and Brigham and Women’s Hospital, Boston, and at various other institutions in England and the USA. Professor Solomon is a member of the editorial board of Drugs of Today and Recent Patents on CNS Drug Discovery, and of Neurodegenerative Diseases. She was awarded the prestigious Zenith Award of the Alzheimer Association, being the first recipient in Israel. She received the Dana Foundation Award for Neuroimmunology. Professor Solomon is the former incumbent of the Chair for Biotechnology of N
eurodegenerative Diseases. In 2007 she was included in Scientific American’s List of 50 of the World’s Leading Innovators. Her scientific interest is focused on the investigation of biorecognition in general and on the nature of the interactions of antibodies and their corresponding antigens in particular.She has the distinction of being the first investigator to recognize the potential for anti –beta antibodies as a therapy for Alzheimer's disease ,being a pioneer in vaccine development against neurodegenerative diseases.